The biology of superagers | Nir Barzilai, MD
Lecture: The biology of superagers
Speaker: Nir Barzilai, MD
Albert Einstein College of Medicine, United States of America
Presented at: International Workshop on HIV & Aging 2017
Learn more about International Workshop on HIV & Aging 2021 that will take place from 23 September 2021 to 24 September 2021 via https://bit.ly/3tiGoJa
The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. The longer life expectancy of people with HIV infection is changing the demographics of the HIV epidemic and currently, more than half of the people living with HIV are aged 45 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, with a greater burden of co-morbidities and associated treatments. In comparison to similar HIV-negative populations, HIV-positive persons, even when on effective ART, experience an excess of morbidity and mortality. Persons on ART rarely die from complications of AIDS, but instead have an early onset of aging complications including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. The high priority of understanding the interaction between age and HIV infection is illustrated by recent summary reports from the HIV and Aging Consensus Project in the Journal of the American Geriatrics Society and ongoing NIH Program Announcements in “Multidisciplinary Studies of HIV/AIDS and Aging”, in addition to strong voices in the community.
Registration for the webinar is open and fee is waived for healthcare professionals via this link https://bit.ly/2R1c2Of
For the Enduring Materials of the 2017 edition visit https://bit.ly/3xZGZTN
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Видео The biology of superagers | Nir Barzilai, MD канала Academic Medical Education
Speaker: Nir Barzilai, MD
Albert Einstein College of Medicine, United States of America
Presented at: International Workshop on HIV & Aging 2017
Learn more about International Workshop on HIV & Aging 2021 that will take place from 23 September 2021 to 24 September 2021 via https://bit.ly/3tiGoJa
The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. The longer life expectancy of people with HIV infection is changing the demographics of the HIV epidemic and currently, more than half of the people living with HIV are aged 45 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, with a greater burden of co-morbidities and associated treatments. In comparison to similar HIV-negative populations, HIV-positive persons, even when on effective ART, experience an excess of morbidity and mortality. Persons on ART rarely die from complications of AIDS, but instead have an early onset of aging complications including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. The high priority of understanding the interaction between age and HIV infection is illustrated by recent summary reports from the HIV and Aging Consensus Project in the Journal of the American Geriatrics Society and ongoing NIH Program Announcements in “Multidisciplinary Studies of HIV/AIDS and Aging”, in addition to strong voices in the community.
Registration for the webinar is open and fee is waived for healthcare professionals via this link https://bit.ly/2R1c2Of
For the Enduring Materials of the 2017 edition visit https://bit.ly/3xZGZTN
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Видео The biology of superagers | Nir Barzilai, MD канала Academic Medical Education
Показать
Комментарии отсутствуют
Информация о видео
26 марта 2021 г. 14:06:38
00:29:18
Другие видео канала
![Preview: Highlights International Workshop on HIV & Women 2021 | Sharon Walmsley, FRCPC, MD, MSC](https://i.ytimg.com/vi/R2YdYyFG4V4/default.jpg)
![A new model for early clinical development of TB drugs and its application... | Norbert Heinrich, MD](https://i.ytimg.com/vi/qFEmqKQZCwU/default.jpg)
![Clinical Considerations of Aging People Living with HIV - Marta Boffito](https://i.ytimg.com/vi/E1EWCXiQ0us/default.jpg)
![The ABC of viral hepatitis | Mark Thursz, MRCP](https://i.ytimg.com/vi/CouyxcDBHRE/default.jpg)
![Updates on WHO HIV Treatment Guidelines - Fujie Zhang, MD, PhD](https://i.ytimg.com/vi/Xyr58KfwWSc/default.jpg)
![Is HCV drug resistance an issue? | Jürgen Rockstroh, MD](https://i.ytimg.com/vi/eMJtOA164uY/default.jpg)
![Is NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF](https://i.ytimg.com/vi/T-U4xYQNp_E/default.jpg)
![Antiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun Sun](https://i.ytimg.com/vi/UyvA6qjkIwU/default.jpg)
![Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD](https://i.ytimg.com/vi/jtTBnIX504w/default.jpg)
![Exercise and aging | Wendy Kohrt, PhD](https://i.ytimg.com/vi/bkVgsTpWIr8/default.jpg)
![Symposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel Discussion](https://i.ytimg.com/vi/FfUrMmnTJag/default.jpg)
![Invitation to join the HIV Prevention Review Meeting 2022 - 30-31 March](https://i.ytimg.com/vi/Xs4wfVPuazY/default.jpg)
![NASH and NAFLD in HIV: same or different? | Mariana Machado, MD](https://i.ytimg.com/vi/zzjGPekecEI/default.jpg)
![Case-Based Discussion of Oral Antivirals for COVID-19: Part 1 - Catia Marzolini, PharmD, PhD](https://i.ytimg.com/vi/AffRMzV0p_g/default.jpg)
![Research into Aging with HIV: Lessons Learned and Outstanding Challenges - Peter Reiss](https://i.ytimg.com/vi/IZ7CCP7pGE0/default.jpg)
![State of the Art Interventions in Improving Pediatric HIV Outcomes in OVC Programs - Grace Mayanja](https://i.ytimg.com/vi/B7JMeVkVOLs/default.jpg)
![Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines .. | Ann Chahroudi, MD, PhD](https://i.ytimg.com/vi/0DnE_AJXX84/default.jpg)
![Invitation by Roger Paredes, MD, PhD | European Meeting on HIV & Hepatitis 2021](https://i.ytimg.com/vi/5MEj0oMZILM/default.jpg)
![Differentiated & Simplified PrEP for HIV Prevention | Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD](https://i.ytimg.com/vi/b1AmSpMLRQA/default.jpg)
![Acute hepatitis A to E, diagnosis and management | Thomas Berg, MD](https://i.ytimg.com/vi/jWQMtxvHUGg/default.jpg)
![Does resistance still matter? | Daniel Kuritzkes, MD](https://i.ytimg.com/vi/l-igc489l0E/default.jpg)